| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | RVNC | Common Stock | 109 K | Feb 27, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | RVNC | Stock Option (Right to buy) | Feb 27, 2024 | Common Stock | 49.7 K | $24.65 | Direct | F1 | ||||||
| holding | RVNC | Performance Stock Units | Feb 27, 2024 | Common Stock | 120 K | $0.00 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The shares subject to the stock option shall vest over a period of four years commencing on October 17, 2022, with 25% vesting on the annual anniversary of the vesting commencement date and 1/48th vesting each month thereafter over the remaining three years, subject to Dr. Hollander's Continuous Service (as defined in the Plan) through each such vesting date. |
| F2 | The performance-based restricted stock units (PSUs) granted to the reporting person on January 31, 2024 represent the right to receive, following vesting, a number of shares of Common Stock up to 150% of the number of PSUs. The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metric, as approved by the Company's Compensation Committee, over a four-year performance period, subject to time based service requirements and continuous employment with the Company through the vesting dates. |
| F3 | The number of securities reported represents the maximum shares that can be earned. |
Exhibit24, Power of Attorney, is attached.